Skip to main content

Endocrine News Features Thyroid Cancer Study Led by Julie Ann Sosa, MD, Chief of Endocrine Surgery

Thursday, January 5, 2017
By Scott Behm, Department of Surgery
Julie Ann Sosa, MD, Chief of Endocrine Surgery

Endocrine News features a story this week on the work of Duke’s endocrinology team and their research study, “How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer,” published in The Journal of Clinical Oncology. The study, led by Dr. Julie Ann Sosa, Chief of Endocrine Surgery, and Dr. Terry Hyslop, Department of Biostatistics and Bioinformatics, used data from the National Cancer Database to quantify the risk of metastatic lymph nodes in thyroid cancer patients. The results of their research will help inform physicians and patients as they consider the benefits and risks of lymphadenectomy in determining the existence of occult disease.

Setting Limits: Lymph Node Removal & Thyroid Cancer

Endocrine News

Read the Article